# ScoreItem: SHBG - Mulheres

**ID:** `019bf31d-2ef0-79e3-911a-8d0944eda087`
**FullName:** SHBG - Mulheres (Exames - Laboratoriais)
**Unit:** nmol/L
**Gender:** female

**Preparation Metadata:**
- Quality Grade: **EXCELLENT**
- Total Chunks: 30 de 11 artigos
- Avg Similarity: 0.682

---

## Contexto

Voc√™ √© um especialista em medicina funcional integrativa e est√° contribuindo com o **Escore Plenya** ‚Äî um escore completo de an√°lise de sa√∫de que avalia todos os aspectos da sa√∫de, performance e longevidade humana. Cada ScoreItem representa um par√¢metro cl√≠nico, laboratorial, gen√©tico, comportamental ou hist√≥rico que comp√µe esse escore.

Seu papel √© gerar conte√∫do cl√≠nico de alta qualidade para enriquecer cada par√¢metro do escore com relev√¢ncia cl√≠nica, orienta√ß√£o ao paciente e conduta pr√°tica.

**Regras inegoci√°veis:**
- Use **apenas** o conhecimento m√©dico real consolidado e os dados presentes nos chunks cient√≠ficos abaixo
- **N√£o alucine, n√£o invente** dados, estudos, estat√≠sticas ou refer√™ncias que n√£o estejam nos chunks ou no seu conhecimento m√©dico estabelecido
- Se um dado espec√≠fico n√£o constar nos chunks e n√£o for do seu conhecimento consolidado, **n√£o o inclua**
- Seja preciso: prefira omitir a inventar

## Instru√ß√£o

Com base nos chunks cient√≠ficos abaixo, gere as respostas em formato JSON.

**O JSON deve obrigatoriamente conter o campo `score_item_id` com o valor `019bf31d-2ef0-79e3-911a-8d0944eda087`.**

```json
{
  "score_item_id": "019bf31d-2ef0-79e3-911a-8d0944eda087",
  "clinical_relevance": "Texto t√©cnico para m√©dicos (1000-5000 chars): defini√ß√£o fisiol√≥gica precisa, valores de refer√™ncia e interpreta√ß√£o, fisiopatologia resumida, dados epidemiol√≥gicos com n√∫meros concretos, estratifica√ß√£o de risco baseada em evid√™ncias.",
  "points": 1,
  "patient_explanation": "Texto simples para pacientes (500-1000 chars): o que √© este par√¢metro sem jarg√µes, por que √© importante para a sa√∫de, o que valores alterados podem significar. Tom tranquilizador e educativo.",
  "conduct": "Conduta cl√≠nica em Markdown (1000-5000 chars): investiga√ß√£o complementar necess√°ria, crit√©rios de encaminhamento a especialistas, interven√ß√µes baseadas em evid√™ncias. Use bullet points, se√ß√µes e negrito."
}
```

**Regras para `points` (1-50):**
- Baixo impacto cl√≠nico: 1-9 pts
- Alto impacto cl√≠nico: 10-19 pts
- Alto impacto em mortalidade: 20-50 pts
- Crit√©rios: gravidade/mortalidade (40%), preval√™ncia (30%), intervencionabilidade (30%)

---

### Contexto Cient√≠fico

**ScoreItem:** SHBG - Mulheres (Exames - Laboratoriais)
**Unidade:** nmol/L
**G√™nero:** female

**30 chunks de 11 artigos (avg similarity: 0.682)**

### Chunk 1/30
**Article:** MFI - Reposi√ß√£o Hormonal - AULA 02 (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.727

anto maior o SHBG, menor a fra√ß√£o livre/biodispon√≠vel.
   - Aproximadamente 38‚Äì40% da testosterona pode estar ligada √† albumina; o total s√©rico pode n√£o refletir a fra√ß√£o acess√≠vel ao corpo.
   - Em homens, alvo t√≠pico de SHBG ideal: 20‚Äì30; em mulheres, par√¢metros s√£o irregulares devido ao uso de anticoncepcionais.
* Modula√ß√£o do SHBG
   - Anticoncepcionais orais e dispositivos como ‚Äúde umireno‚Äù elevam SHBG por efeito hep√°tico; tentar baixar o SHBG nesses casos √© in√∫til e potencialmente delet√©rio, pois √© uma resposta protetiva do corpo a horm√¥nios sint√©ticos.
   - SHBG muito baixo √© frequente em diab√©ticos e pode sinalizar disfun√ß√£o/inflama√ß√£o; extremos (muito baixo ou muito alto) indicam anormalidade.
   - SHBG tem receptores e pode liberar horm√¥nios; a din√¢mica de libera√ß√£o n√£o √© totalmente compreendida. Manejar SHBG requer vis√£o cl√≠nica individual, n√£o ‚Äúbaixar a qualquer custo‚Äù.
### 4.

---

### Chunk 2/30
**Article:** Psiquiatria Metab√≥lica Funcional Integrativa AULA 19 (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.712

na ligadora de horm√¥nios sexuais), que se liga com alta afinidade √† testosterona, reduzindo sua biodisponibilidade.
   - H√° menor s√≠ntese de testosterona ovariana por bloqueio de LH e poss√≠vel redu√ß√£o de androg√™nese adrenal; a produ√ß√£o feminina j√° √© limitada, agravada pela SHBG elevada.
* Medi√ß√£o e terap√™utica de testosterona em mulheres
   - Teste sangu√≠neo de testosterona feminina √© pouco fidedigno devido aos n√≠veis muito baixos; avalia√ß√£o salivar √© considerada mais precisa, assim como cortisol salivar.
   - Prescri√ß√£o: em mulheres sem anticoncepcionais e com sintomas (fadiga, baixa libido), podem-se testar baixas doses de creme de testosterona com avalia√ß√£o de resposta; n√£o esperar ganho de massa magra com creme.
   - Em usu√°rias de anticoncepcionais, recuperar testosterona livre √© dif√≠cil; seriam necess√°rias ‚Äúmega doses‚Äù, o que n√£o vale pela captura pela SHBG.

---

### Chunk 3/30
**Article:** MFI - Reposi√ß√£o Hormonal - AULA 03 (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.711

, estradiol (cr√≠tico para desejo), diidrotestosterona (DHT), ovula√ß√£o, atra√ß√£o f√≠sica, sono; contraceptivos e ins√¥nia alteram fortemente.
* Exames e confiabilidade
   - Exames de testosterona para mulheres s√£o pouco confi√°veis; deve-se priorizar a cl√≠nica e considerar teste terap√™utico, monitorando exames para evitar excesso. Mesmo com testosterona ‚Äúalta‚Äù em laborat√≥rio, receptores hormonais podem variar.
   - Anticoncepcionais combinados elevam SHBG, reduzem testosterona livre e atrapalham resposta √† reposi√ß√£o. Com anticoncepcional, a testosterona administrada tende a ser sequestrada pelo SHBG, reduzindo efetividade.
* Manejo pr√°tico
   - Considerar retirar p√≠lula quando poss√≠vel: pode ocorrer queda de cabelo, acne e ‚Äúdesbagun√ßa‚Äù hormonal por cerca de 3 meses; com sa√∫de e suporte (suplementa√ß√£o, alimenta√ß√£o, exerc√≠cio, modula√ß√£o do eixo HPA, mitoc√¥ndrias), tende a estabilizar.

---

### Chunk 4/30
**Article:** Emagrecimento XII (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.707

serir Nome da Aula]: [Inserir Nome da Aula]
## Vis√£o Geral
A aula abordou os impactos de contraceptivos hormonais, medicamentos e condi√ß√µes metab√≥licas na sa√∫de da mulher e na perda de peso. Foram discutidos os efeitos negativos dos contraceptivos (aumento do SHBG, risco de AVC, depress√£o), o manejo dos efeitos colaterais p√≥s-suspens√£o (queda de cabelo, acne), o uso e mecanismos da metformina na SOP e perda de peso, e os impactos negativos das estatinas no metabolismo da glicose e fun√ß√£o mitocondrial. A sess√£o concluiu com uma cr√≠tica √† desinforma√ß√£o nutricional e uma defesa da abordagem integrativa na sa√∫de.
## Conte√∫do Remanescente
1. Detalhes sobre a reposi√ß√£o hormonal masculina (doses, prescri√ß√£o, indica√ß√µes).
2. Como medir o DHT na saliva e interpretar os resultados.
3. Aprofundamento nos mecanismos de prote√ß√£o do estrog√™nio para os fol√≠culos capilares.
4. Regula√ß√£o end√≥crina de curto prazo.
5.

---

### Chunk 5/30
**Article:** Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome (2020)
**Journal:** International Journal of Molecular Sciences
**Section:** other | **Similarity:** 0.705

nhealthyfemalesandmalesfrombirthuntiloldage.Clin.Lab.2005,51,625‚Äì632.31.Garc√©s,C.;Oya,I.;Lasunci√≥n,M.A.;L√≥pez-Sim√≥n,L.;Cano,B.;deOya,M.Sexhormone-bindingglobulinandlipidproÔ¨Åleinpubertalchildren.Metabolism2010,59,166‚Äì171.[CrossRef]32.Murphy,A.;Cropp,C.S.;Smith,B.S.;Burkman,R.T.;Zacur,H.A.EÔøΩectoflow-doseoralcontraceptiveongonadotropins,androgens,andsexhormonebindingglobulininnonhirsutewomen.FertilSteril.1990,53,35‚Äì39.[CrossRef]33.Rannevik,G.;Jeppsson,S.;Johnell,O.;Bjerre,B.;Laurell-Borulf,Y.;Svanberg,L.Alongitudinalstudyoftheperimenopausaltransition:AlteredproÔ¨Ålesofsteroidandpituitaryhormones,SHBGandbonemineraldensity.Maturitas1995,21,103‚Äì113.[CrossRef]34.Selva,D.M.;Hogeveen,K.N.;Innis,S.M.;Hammond,G.L.Monosaccharide-inducedlipogenesisregulatesthehumanhepaticsexhormone-bindingglobulingene.J.Clin.Investig.2007,117,3979‚Äì3987.[CrossRef]35.Feng,C.;Jin,Z.;Sun,L.;Wang,X.;Chi,X.;Zhang,X.;Lian,S.EndogenousSHBGlevelscorrelatewiththatofglucosetransportersininsulinresistancemode

---

### Chunk 6/30
**Article:** MFI - Reposi√ß√£o Hormonal - AULA 04 (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.693

itos.
- Queda de cabelo acentuada.
- TPM muito intensa em mulheres.
## Objetivo:
Aula, n√£o consulta. Achados objetivos/patol√≥gicos gerais:
- Testosterona em homens diminui com a idade; n√≠veis <400 ng/dL s√£o considerados baixos.
- Baixa testosterona associada a maior ocorr√™ncia de obesidade, hipertens√£o, hiperlipidemia, alergias e diabetes.
- Alta preval√™ncia de hipogonadismo hipogonadotr√≥fico (falta de comando central) em homens obesos.
- Obesidade aumenta atividade da aromatase, resist√™ncia √† insulina e apneia do sono, levando a hipogonadismo hipotal√¢mico.
- Obesidade pode elevar a temperatura escrotal, piorar produ√ß√£o de testosterona e levar a oligospermia/azoospermia.
- Exames de sangue para horm√¥nios livres (ex.: testosterona livre) s√£o imprecisos no Brasil, pois laborat√≥rios calculam em vez de medir diretamente; ~80% dos horm√¥nios livres aderem √†s hem√°cias e s√£o removidos na centrifuga√ß√£o.

---

### Chunk 7/30
**Article:** Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome (2020)
**Journal:** International Journal of Molecular Sciences
**Section:** discussion | **Similarity:** 0.692

;Yao,A.;Shi,K.MetaboliceÔøΩectofobesityonpolycysticovarysyndromeinadolescents:Ameta-analysis.J.Obstet.Gynaecol.2017,37,1036‚Äì1047.[CrossRef]23.Chen,M.J.;Yang,W.S.;Yang,J.H.;Hsiao,C.K.;Yang,Y.S.;Ho,H.N.Lowsexhormone-bindingglobulinisassociatedwithlowhigh-densitylipoproteincholesterolandmetabolicsyndromeinwomenwithPCOS.Hum.Reprod.2006,21,2266‚Äì2271.[CrossRef]24.West,S.;Lashen,H.;Bloigu,A.;Franks,S.;Puukka,K.;Ruokonen,A.;J√§rvelin,M.R.;Tapanainen,J.S.;Morin-Papunen,L.Irregularmenstruationandhyperandrogenaemiainadolescenceareassociatedwithpolycysticovarysyndromeandinfertilityinlaterlife:NorthernFinlandBirthCohort1986study.Hum.Reprod.2014,29,2339‚Äì2351.[CrossRef][PubMed]25.Hammond,G.L.;Bocchinfuso,W.P.Sexhormone-bindingglobulin:Geneorganizationandstructure/functionanalyses.Horm.Res.1996,45,197‚Äì201.[CrossRef]26.Lee,I.R.;Dawson,S.A.;Wetherall,J.D.;Hahnel,R.Sexhormone-bindingglobulinsecretionbyhumanhepatocarcinomacellsisincreasedbybothestrogensandandrogens.J.Clin.Endocrinol.Metab.1987,64,

---

### Chunk 8/30
**Article:** Testosterone in women‚Äîthe clinical significance (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.690

reduces liver fat is associated with 
an increase in SHBG, an eÔ¨Ä ect that seems to be independent of 
insulin resistance.44,45 In postmenopausal women, the free androgen index (FAI, calculated as total 
testosterone √∑ SHBG √ó 100), but not total testosterone, is 
associated with the metabolic syndrome and an increased risk 
of cardiovascular disease.51,52 Thus, concentrations of SHBG but not testosterone explain the association between FAI and free 
fraction of testosterone‚Äîand other sex steroids‚Äîin plasma, but 
low concentrations of SHBG are an independent risk factor for 
insulin resistance, type 2 diabetes, and adverse lipid proÔ¨Å le in young women and women at midlife.44,46,47
	
	
Getulio Jos√© Mattos Do Amaral Filho - getfilho@yahoo.com.br - CPF: 034.983.039-88

www.thelancet.com/diabetes-endocrinology   Published online September 8, 2015   http://dx.doi.org/10.1016/S2213-8587(15)00284-3 7Review
and have anti-inÔ¨Ç ammatory action

---

### Chunk 9/30
**Article:** Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome (2020)
**Journal:** International Journal of Molecular Sciences
**Section:** other | **Similarity:** 0.689

Ref]43.S√∏rensen,K.;Aksglaede,L.;Munch-Andersen,T.;Aachmann-Andersen,N.J.;Petersen,J.H.;Hilsted,L.;Helge,J.W.;Juul,A.Sexhormone-bindingglobulinlevelspredictinsulinsensitivity,dispositionindex,andcardiovascularriskduringpuberty.DiabetesCare2009,32,909‚Äì914.[CrossRef]44.Le,S.;Xu,L.;Schumann,M.;Wu,N.;T√∂rm√§kangas,T.;Al√©n,M.;Cheng,S.;Wiklund,P.Doessexhormone-bindingglobulincauseinsulinresistanceduringpubertalgrowth?Endocr.Connect.2019,8,510‚Äì517.[CrossRef]45.Kavanagh,K.;Espeland,M.A.;Sutton-Tyrrell,K.;Barinas-Mitchell,E.;ElKhoudary,S.R.;Wildman,R.P.LiverfatandSHBGaÔøΩectinsulinresistanceinmidlifewomen:TheStudyofWomen‚ÄôsHealthAcrosstheNation(SWAN).Obesity2013,21,1031‚Äì1038.[CrossRef]46.Lin,X.F.;Wu,R.R.;Du,J.;Liao,Y.C.;Du,Y.;Ye,Y.;Wang,Y.;Zhang,X.B.;Wu,C.;Chen,A.ExploringthesigniÔ¨Åcanceofsexhormone-bindingglobulinexaminationinthetreamentofwomenwithpolycysticovariansyndrome(PCOS).Clin.Exp.Obstet.Gynecol.2015,42,315‚Äì320.47.Pasquali,R.;Gambineri,A.;Biscotti,D.;Vicennati,V.;Gagliardi,L.

---

### Chunk 10/30
**Article:** Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome (2020)
**Journal:** International Journal of Molecular Sciences
**Section:** other | **Similarity:** 0.688

ingglobulingene.J.Clin.Investig.2007,117,3979‚Äì3987.[CrossRef]35.Feng,C.;Jin,Z.;Sun,L.;Wang,X.;Chi,X.;Zhang,X.;Lian,S.EndogenousSHBGlevelscorrelatewiththatofglucosetransportersininsulinresistancemodelcells.Mol.Biol.Rep.2019,46,4953‚Äì4965.[CrossRef]36.Loukovaara,M.;Carson,M.;Adlercreutz,H.Regulationofproductionandsecretionofsexhormone-bindingglobulininHepG2cellculturesbyhormonesandgrowthfactors.J.Clin.Endocrinol.Metab.1995,80,160‚Äì164.37.Selva,D.M.;Hammond,G.L.Thyroidhormonesactindirectlytoincreasesexhormone-bindingglobulinproductionbyliverviahepatocytenuclearfactor-4alpha.J.Mol.Endocrinol.2009,43,19‚Äì27.[CrossRef]38.Pugeat,M.;Nader,N.;Hogeveen,K.;Raverot,G.;D√©chaud,H.;Grenot,C.Sexhormone-bindingglobulingeneexpressionintheliver:Drugsandthemetabolicsyndrome.Mol.CellEndocrinol.2010,316,53‚Äì59.[CrossRef]39.Zhu,J.L.;Chen,Z.;Feng,W.J.;Long,S.L.;Mo,Z.C.Sexhormone-bindingglobulinandpolycysticovarysyndrome.Clin.Chim.Acta2019,499,142‚Äì148.[CrossRef]40.Xie,X.;Liao,H.;Dang,H.;Pang,W.;Guan,Y

---

### Chunk 11/30
**Article:** Testosterone in women‚Äîthe clinical significance (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.686

Panel: Taking sex hormone-binding globulin into accountTestosterone in women is most often considered in the context of excess concentrations and polycystic ovary syndrome. Hyperinsulinaemia, androgen excess, and the metabolic 
syndrome characterise polycystic ovary syndrome. A hallmark of 
polycystic ovary syndrome is low concentrations of sex 
hormone-binding globulin (SHBG), which, in turn, are 
associated with the higher risk proÔ¨Å le for cardiovascular disease 
seen in this disorder. Strong evidence shows that SHBG is 
metabolically important and not simply a transport protein for 
sex steroids.

---

### Chunk 12/30
**Article:** Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome (2020)
**Journal:** International Journal of Molecular Sciences
**Section:** other | **Similarity:** 0.681

3‚Äì59.[CrossRef]39.Zhu,J.L.;Chen,Z.;Feng,W.J.;Long,S.L.;Mo,Z.C.Sexhormone-bindingglobulinandpolycysticovarysyndrome.Clin.Chim.Acta2019,499,142‚Äì148.[CrossRef]40.Xie,X.;Liao,H.;Dang,H.;Pang,W.;Guan,Y.;Wang,X.;Shyy,J.Y.;Zhu,Y.;Sladek,F.M.Down-regulationofhepaticHNF4alphageneexpressionduringhyperinsulinemiaviaSREBPs.Mol.Endocrinol.2009,23,434‚Äì443.[CrossRef]

Int.J.Mol.Sci.2020,21,819114of1741.Feng,C.;Jin,Z.;Chi,X.;Zhang,B.;Wang,X.;Sun,L.;Fan,J.;Sun,Q.;Zhang,X.SHBGexpressioniscorrelatedwithPI3K/AKTpathwayactivityinacellularmodelofhumaninsulinresistance.Gynecol.Endocrinol.2018,34,567‚Äì573.[CrossRef][PubMed]42.Saez-Lopez,C.;Villena,J.A.;Sim√≥,R.;Selva,D.M.Sexhormone-bindingglobulinoverexpressionprotectsagainsthighfatdietinducedobesityintransgenicmalemice.J.Nutr.Biochem.2020,85,108480.[CrossRef]43.S√∏rensen,K.;Aksglaede,L.;Munch-Andersen,T.;Aachmann-Andersen,N.J.;Petersen,J.H.;Hilsted,L.;Helge,J.W.;Juul,A.Sexhormone-bindingglobulinlevelspredictinsulinsensitivity,dispositionindex,andcardi

---

### Chunk 13/30
**Article:** Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome (2020)
**Journal:** International Journal of Molecular Sciences
**Section:** other | **Similarity:** 0.680

TheBiochemistryandEndocrinologyofSHBGSHBGisa90‚Äì100KDahomodimericglycoproteinwithtwoidenticalpeptidechainsthatisencodedbyasinglegeneontheshortarmofchromosome17[25].CirculatingSHBGisproducedprimarilybyhepatocytes,however,thegeneisalsoexpressedinthebrain,uterus,breast,ovary,placenta,prostate

Int.J.Mol.Sci.2020,21,81914of17andtestis[26,27].SHBGbindsandtransportstestosterone,estradiolandothersexsteroidsintheplasma,reducestheirmetabolicclearancerateandaÔøΩectstheirbioavailability[28].SHBGexhibitshighaÔøΩnityfortestosteroneandalowaÔøΩnityforestradiol.TherelativebindingaÔøΩnityofvarioussexsteroidsforSHBGisdihydrotestosterone(DHT)>testosterone>androstenediol>estradiol>estrone[28].ThefreeactivetestosteroneconcentrationsinplasmaareverymuchinÔ¨ÇuencedbySHBGconcentrationsbecauseonly1‚Äì2%oftestosteroneinthecirculationisfree(unbound)andactive;65%isboundtoSHBGandtherestisboundtoalbumin[28].Therefore,womenwithlowSHBGcanhavenormaltotaltestosteronelevelsbutelevatedbioavailable-andfree-testosteronelev

---

### Chunk 14/30
**Article:** The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review (2022)
**Journal:** International Journal of Impotence Research
**Section:** other | **Similarity:** 0.679

andpatientbasedonthepatient‚Äôsgoalsofcareafterdetailedcounselingregardingthebenetsandrisksoftheoff-labeluseoftestosteronetherapyinwomen[58,59].Patientsshouldalsobemadeawarethatdueto
Table1.FactorsthatincreaseordecreaselevelsofSHBGinwomen.FactorsthatincreasesexhormonebindinggobulinFactorsthatdecreasesexhormonebindinggobulinAgingObesityInfectiousdisease(HIV,HepatitisC)Diabetes,insulinresistanceHyperthyrodismHypothyroidism
HepatocellulardysfunctionPolycysticovariansyndromeElevatedestrogenHyperprolactinaemiaMedications(thiazolidines,anticonvulsants,oralcontraceptives,selectiveestrogenreceptormodulators)Medications(glucocorticoids,tyrosinekinase,inhibitors,androgens)SexhormonebindingpolymorphismsHypercorticism
ExtremeweightlossAcromegalyNephroticsyndrome
Table2.Referencerangesoftestosteronelevelinwomenbasedonage.AgesReferencerangeoftestosteroneproductionbyovariesandadrenalglands(ng/dL)20‚Äì29years45.5‚Äì57.5ng/dL20‚Äì39years27.6‚Äì39.8ng/dL40‚Äì49years27.0‚Äì38.6ng/dL
M.Ulokoetal.637IJIR:

---

### Chunk 15/30
**Article:** Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome (2020)
**Journal:** International Journal of Molecular Sciences
**Section:** discussion | **Similarity:** 0.678

yexistinwomenwithNAFLD.4.3.SHBGLevelsinAdultWomenwithPCOSArecentsystematicreviewandmeta-analysisof59registeredclinicaltrialsindicatedapositivecorrelationbetweenmetabolicsyndromeandPCOS[80].Interestingly,themeta-analysisfound,in

Int.J.Mol.Sci.2020,21,81918of17goodandfairqualitystudies,thatwomenwithPCOShavehadobesityrelatedmetabolicabnormalitiesassociatedwithsigniÔ¨ÅcantlylowerSHBGlevelsbutnotwithindicesofhyperandrogenism[81],whichhighlightsthepossibilitythatdecreasedSHBGoccurspriortoincreasedandrogensinPCOS.Furthermore,therapeuticinterventionwithmetformin,myo-inositolandD-chiro-inositolinwomenwithPCOSincreasedserumlevelsofSHBGandwereassociatedwithimprovedovarianfunctionandmetabolism(reductionofBMI,HOMA-IRandLDL-C)[47,82].Therefore,serumSHBGlevelsmayprovetobeausefulbiomarkerforthediagnosisandtreatmentofPCOS[83].4.4.SHBGLevelsinPCOSAdolescentsWithwesternizedlifestylesworldwide,obesityhasgreatlyincreasedamongteenagersandchildren.Obesityimpactsthedevelopmentofgirlsduringpubertyandincreases

---

### Chunk 16/30
**Article:** S√≠ndrome dos Ov√°rios Polic√≠sticos - Parte II (2024)
**Journal:** Pos Graduacao MFI
**Section:** discussion | **Similarity:** 0.678

1.000‚Äì2.000 mg/dia com enhancers de biodisponibilidade.
  - Coenzima Q10: suporte √† foliculog√™nese e resposta a indutores.
## Diagn√≥stico Principal:
- Avalia√ß√£o: SOP em discuss√£o, com foco em resist√™ncia √† insulina, hiperandrogenismo, irregularidade menstrual, riscos e impactos de COCs, e estrat√©gias de manejo metab√≥lico e reprodutivo. Conte√∫do educacional; sem confirma√ß√£o em paciente espec√≠fico.
- Diagn√≥stico Suspeito: Nenhum no momento.
## Plano:
- Prescri√ß√£o:
  - Inserir de acordo com o caso individual.
  - Op√ß√µes discutidas:
    - Metformina XR at√© 1.500 mg/dia (avaliar renal, B12/B6/folato).
    - Mio-inositol 2 g + √°cido f√≥lico 200 mcg, 2x/dia; considerar alfa-lactoalbumina 50 mg, 2x/dia.
    - Progesterona micronizada oral em esquema c√≠clico: 200 mg/dia por 10‚Äì14 dias do ciclo (ex.: dias 15‚Äì24); monitorar humor/sono.
    - Antiandrog√™nios em sintomas: espironolactona, finasterida; considerar Serenoa repens 400 mg em acne/hirsutismo.

---

### Chunk 17/30
**Article:** Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome (2020)
**Journal:** International Journal of Molecular Sciences
**Section:** other | **Similarity:** 0.678

sexhormone-bindingglobulinexaminationinthetreamentofwomenwithpolycysticovariansyndrome(PCOS).Clin.Exp.Obstet.Gynecol.2015,42,315‚Äì320.47.Pasquali,R.;Gambineri,A.;Biscotti,D.;Vicennati,V.;Gagliardi,L.;Colitta,D.;Fiorini,S.;Cognigni,G.E.;Filicori,M.;Morselli-Labate,A.M.EÔøΩectoflong-termtreatmentwithmetforminaddedtohypocaloricdietonbodycomposition,fatdistribution,andandrogenandinsulinlevelsinabdominallyobesewomenwithandwithoutthepolycysticovarysyndrome.J.Clin.Endocrinol.Metab.2000,85,2767‚Äì2774.[CrossRef]48.Plymate,S.R.;Matej,L.A.;Jones,R.E.;Friedl,K.E.Inhibitionofsexhormone-bindingglobulinproductioninthehumanhepatoma(HepG2)celllinebyinsulinandprolactin.J.Clin.Endocrinol.Metab.1988,67,460‚Äì464.[CrossRef]49.Pasquali,R.;Casimirri,F.;DeIasio,R.;Mesini,P.;Boschi,S.;Chierici,R.;Flamia,R.;Biscotti,M.;Vicennati,V.Insulinregulatestestosteroneandsexhormone-bindingglobulinconcentrationsinadultnormalweightandobesemen.J.Clin.Endocrinol.Metab.1995,80,654‚Äì658.50.Dapas,M.;Lin,F.T.;Nadkarni,G.N.;Si

---

### Chunk 18/30
**Article:** Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome (2020)
**Journal:** International Journal of Molecular Sciences
**Section:** other | **Similarity:** 0.678

ReviewSexHormone-BindingGlobulin(SHBG)asanEarlyBiomarkerandTherapeuticTargetinPolycysticOvarySyndromeXianqinQu1,*andRichardDonnelly21SchoolofLifeSciences,UniversityofTechnologySydney,Ultimo,NSW2007,Australia2SchoolofMedicine,UniversityofNottingham,DerbyDE223DT,UK;richard.donnelly@nottingham.edu.uk*Correspondence:Xianqin.Qu@uts.edu.au;Tel.:+61-2-95147852Received:1October2020;Accepted:28October2020;Published:1November2020
Abstract:Humansexhormone-bindingglobulin(SHBG)isaglycoproteinproducedbytheliverthatbindssexsteroidswithhighaÔøΩnityandspeciÔ¨Åcity.ClinicalobservationsandreportsintheliteraturehavesuggestedanegativecorrelationbetweencirculatingSHBGlevelsandmarkersofnon-alcoholicfattyliverdisease(NAFLD)andinsulinresistance.DecreasedSHBGlevelsincreasethebioavailabilityofandrogens,whichinturnleadstoprogressionofovarianpathology,anovulationandthephenotypiccharacteristicsofpolycysticovariansyndrome(PCOS).Thisreviewwilluseacasereporttoillustratetheinter-relationshipsbetweenSHBG,NAFLDandPCOS.I

---

### Chunk 19/30
**Article:** Psiquiatria Metab√≥lica Funcional Integrativa AULA 19 (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.676

de contraceptivos orais pelo risco de trombose e AVC; descrito como barato e efetivo.
   - Prescri√ß√£o especialmente considerada diante de deple√ß√µes ou altera√ß√µes de folato, homociste√≠na, B12, B6; o instrutor solicita esses exames a todas as pacientes h√° mais de 15 anos.
* Deple√ß√µes e altera√ß√µes metab√≥licas provocadas por contraceptivos orais combinados
   - Podem aumentar resist√™ncia insul√≠nica; provocar deslipidemia e intoler√¢ncia √† glicose.
   - Podem reduzir folato e vitamina B12; depletar vitaminas B6, B2, C, E e minerais zinco, magn√©sio, sel√™nio.
   - Essas deple√ß√µes impactam processos metab√≥licos de humor e energia discutidos anteriormente.
### 3. Contraceptivos orais e horm√¥nios androg√™nicos
* SHBG e testosterona
   - Contraceptivos orais elevam SHBG (prote√≠na ligadora de horm√¥nios sexuais), que se liga com alta afinidade √† testosterona, reduzindo sua biodisponibilidade.

---

### Chunk 20/30
**Article:** S√≠ndrome dos Ov√°rios Polic√≠sticos - Parte II (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.674

; em descend√™ncia asi√°tica, ‚â•4.
- Exames laboratoriais para diferenciais:
  - Prolactina (hiperprolactinemia).
  - 17-OHP (HAC n√£o cl√°ssica).
  - TSH, T4 (¬± T3) para disfun√ß√£o tireoidiana.
  - Testosterona total/livre, DHEA-S (tumores secretores/uso ex√≥geno).
  - USG p√©lvica; RM/TC se suspeita de tumores.
  - S√≠ndrome de Cushing: cortisol salivar noturno ou teste de supress√£o com dexametasona 1 mg (se suspeita cl√≠nica).
- Achados cl√≠nicos gerais:
  - Irregularidade menstrual frequente; ciclos <21 dias, oligomenorreia >35 dias, amenorreia ‚â•3 meses ou <8 menstrua√ß√µes/ano.
  - Sangramento uterino anormal de causa ovulat√≥ria (n√£o estrutural) pode ocorrer.
  - Fen√≥tipo A (tr√™s crit√©rios presentes) com maior risco de complica√ß√µes metab√≥licas.

---

### Chunk 21/30
**Article:** Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome (2020)
**Journal:** International Journal of Molecular Sciences
**Section:** other | **Similarity:** 0.673

sandgirlsduringpubertyhaveshownthatSHBGisastrongpredictorofinsulinsensitivityandadeclineinSHBGpredictsthedevelopmentofinsulinresistance[43,44].TheStudyofWomen‚ÄôsHealthAcrosstheNation(SWAN)revealedthatincreasedliverfatanddecreasedSHBGassociatedwithincreasedmetabolicriskinmidlife,whiletherewasalsoanegativeassociationbetweenSHBGandinsulinamongwomenwithfattylivers[45].SHBGregulatesthebioactivityofsexhormones.Insulinresistanceleadstohyperinsulinemia,whichinturncausesreproductivedysfunctionbydown-regulatingSHBGproduction[46].Furthermore,therapieswhichreverseinsulinresistance,forexample,metformin,areassociatedwithanincreaseinSHBGconcentrationsinwomenwithPCOS[47].Accordingly,SHBGhasemergedasabiomarkerofinsulinresistance.However,themechanismforthisassociationremainsunclear.InvitrostudiesusinghepatomacelllinesdemonstratethathighconcentrationsofinsulininhibitSHBGproduction[48].Also,invivoinhibitionofinsulinsecretionwithdiazoxideleadstoincreasedSHBGconcentrations,suggestingthatinsulininhibitshepa

---

### Chunk 22/30
**Article:** Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome (2020)
**Journal:** International Journal of Molecular Sciences
**Section:** other | **Similarity:** 0.672

97‚Äì201.[CrossRef]26.Lee,I.R.;Dawson,S.A.;Wetherall,J.D.;Hahnel,R.Sexhormone-bindingglobulinsecretionbyhumanhepatocarcinomacellsisincreasedbybothestrogensandandrogens.J.Clin.Endocrinol.Metab.1987,64,825‚Äì831.[CrossRef]27.Hammond,G.L.Diverserolesforsexhormone-bindingglobulininreproduction.Biol.Reprod.2011,85,431‚Äì441.[CrossRef]28.Dunn,J.F.;Nisula,B.C.;Rodbard,D.Transportofsteroidhormones:Bindingof21endogenoussteroidstobothtestosterone-bindingglobulinandcorticosteroid-bindingglobulininhumanplasma.J.Clin.Endocrinol.Metab.1981,53,58‚Äì68.[CrossRef][PubMed]29.Karakas,S.E.Newbiomarkersfordiagnosisandmanagementofpolycysticovarysyndrome.Clin.Chim.Acta2017,471,248‚Äì253.[CrossRef]30.Elmlinger,M.W.;K√ºhnel,W.;Wormstall,H.;D√∂ller,P.C.Referenceintervalsfortestosterone,androstenedioneandSHBGlevelsinhealthyfemalesandmalesfrombirthuntiloldage.Clin.Lab.2005,51,625‚Äì632.31.Garc√©s,C.;Oya,I.;Lasunci√≥n,M.A.;L√≥pez-Sim√≥n,L.;Cano,B.;deOya,M.Sexhormone-bindingglobulinandlipidproÔ¨Åleinpubertalchildre

---

### Chunk 23/30
**Article:** S√≠ndrome dos Ov√°rios Polic√≠sticos - Parte I (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.672

m: obesidade, sedentarismo, m√° alimenta√ß√£o, dislipidemia, esteatose hep√°tica, hiperandrogenismo, resist√™ncia √† insulina, inflama√ß√£o cr√¥nica, disbiose intestinal, estresse oxidativo, disfun√ß√£o mitocondrial e exposi√ß√£o a desreguladores end√≥crinos.
2.  **Hist√≥rico de Medica√ß√£o:** Inserir mais aqui
## Subjetivo:
O conte√∫do √© uma palestra informativa sobre a S√≠ndrome dos Ov√°rios Polic√≠sticos (SOP) e n√£o um registro de um paciente espec√≠fico. O texto n√£o cont√©m queixas subjetivas de um paciente.
## Objetivo:
O conte√∫do √© uma palestra informativa sobre a S√≠ndrome dos Ov√°rios Polic√≠sticos (SOP) e n√£o cont√©m achados de exames de um paciente espec√≠fico.

---

### Chunk 24/30
**Article:** S√≠ndrome dos Ov√°rios Polic√≠sticos - Parte II (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.669

m paciente espec√≠fico; o conte√∫do descreve orienta√ß√£o cl√≠nica geral sobre SOP, incluindo:
  - Dificuldade de controle metab√≥lico apesar de exerc√≠cios/dieta.
  - Irregularidade menstrual e anovula√ß√£o.
  - Hiperandrogenismo (acne, hirsutismo).
  - Ansiedade, irritabilidade, dificuldade de sono.
  - Infertilidade, potencial risco CV associado √† hiper-homocisteinemia.
## Objetivo:
- Crit√©rios diagn√≥sticos (Roterd√£): requer 2 de 3 para SOP:
  - Irregularidade menstrual/anuvolu√ß√£o cr√¥nica (oligomenorreia, amenorreia).
  - Hiperandrogenismo cl√≠nico/biol√≥gico (acne, hirsutismo; viriliza√ß√£o √© incomum e sugere tumores/andr√≥genos ex√≥genos).
  - Ov√°rios polic√≠sticos na ultrassonografia (n√£o obrigat√≥rio).
- Escalas/avalia√ß√µes:
  - Ferriman-Gallwey (hirsutismo): ‚â•6 (geral); em descend√™ncia asi√°tica, ‚â•4.
- Exames laboratoriais para diferenciais:
  - Prolactina (hiperprolactinemia).
  - 17-OHP (HAC n√£o cl√°ssica).
  - TSH, T4 (¬± T3) para disfun√ß√£o tireoidiana.

---

### Chunk 25/30
**Article:** Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome (2020)
**Journal:** International Journal of Molecular Sciences
**Section:** discussion | **Similarity:** 0.667

tti,M.;Vicennati,V.Insulinregulatestestosteroneandsexhormone-bindingglobulinconcentrationsinadultnormalweightandobesemen.J.Clin.Endocrinol.Metab.1995,80,654‚Äì658.50.Dapas,M.;Lin,F.T.;Nadkarni,G.N.;Sisk,R.;Legro,R.S.;Urbanek,M.;Hayes,M.G.;Dunaif,A.Distinctsubtypesofpolycysticovarysyndromewithnovelgeneticassociations:Anunsupervised,phenotypicclusteringanalysis.PLoSMed.2020,17,e1003132.[CrossRef]51.Petersen,M.C.;Shulman,G.I.MechanismsofInsulinActionandInsulinResistance.Physiol.Rev.2018,98,2133‚Äì2223.[CrossRef]52.Wang,Y.;Viscarra,J.;Kim,S.J.;Sul,H.S.Transcriptionalregulationofhepaticlipogenesis.Nat.Rev.Mol.CellBiol.2015,16,678‚Äì689.[CrossRef]53.Winters,S.J.;Gogineni,J.;Karegar,M.;Scoggins,C.;Wunderlich,C.A.;Baumgartner,R.;Ghooray,D.T.Sexhormone-bindingglobulingeneexpressionandinsulinresistance.J.Clin.Endocrinol.Metab.2014,99,E2780‚ÄìE2788.[CrossRef][PubMed]54.S√°ez-L√≥pez,C.;Salcedo-Allende,M.T.;Hernandez,C.;Sim√≥-Servat,O.;Sim√≥,R.;Selva,D.M.SexHormone-BindingGlobulinExpressionCorrelat

---

### Chunk 26/30
**Article:** S√≠ndrome dos Ov√°rios Polic√≠sticos - Parte I (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.666

*
- Quase 60% das mulheres com SOP reportam insatisfa√ß√£o com os cuidados m√©dicos atuais.
- O dado sinaliza falhas em educa√ß√£o, rastreio precoce e personaliza√ß√£o terap√™utica.
**Achados Metab√≥licos e de Sinaliza√ß√£o sustentam o risco para diabetes tipo 2.**
- A SOP est√° associada √† diabetes mellitus tipo 2, ligada √† resist√™ncia √† insulina e hiperinsulinemia.
- Elementos da via de sinaliza√ß√£o da insulina (PI3K) e falhas na transloca√ß√£o do GLUT4 comprometem a capta√ß√£o de glicose, contribuindo para resist√™ncia √† insulina.
**Achados Adicionais**
- 17-hidroxiprogesterona √© citada no contexto de excesso androg√™nico e desequil√≠brio com androstenediona, como poss√≠vel marcador hormonal espec√≠fico.
- O risco de diabetes tipo 2 est√° aumentado em mulheres com SOP devido ao descontrole metab√≥lico associado.

---

### Chunk 27/30
**Article:** MFI - Reposi√ß√£o Hormonal - AULA 04 (2024)
**Journal:** Pos Graduacao MFI
**Section:** discussion | **Similarity:** 0.665

tosterona livre‚Äù calculada do soro como decisor; incluir, quando indicado, painel salivar (testosterona, DHT, estradiol; progesterona no D22‚ÄìD24) juntamente com sangue total e SHBG.
- [ ] 5. Implementar triagem de fatores ambientais/ocupacionais que elevem temperatura escrotal (vestimenta apertada, longos per√≠odos sentado, dormir de cueca, ambientes quentes) e orientar medidas corretivas.
- [ ] 6. Estabelecer protocolo para avalia√ß√£o p√≥s-ciclo de testosterona (end√≥gena/ex√≥gena), reconhecendo per√≠odos de LH/FSH inibidos e evitando interpreta√ß√µes equivocadas de queda transit√≥ria.
- [ ] 7. Preparar leitura dos estudos recomendados sobre obesidade e hipogonadismo, bari√°trica e revers√£o hormonal, e rela√ß√µes entre obesidade e andropausa, para discuss√£o na pr√≥xima aula.
- [ ] 8. Educar equipes cl√≠nicas sobre a inadequa√ß√£o de prescrever inibidores de PDE5 (Viagra/Cialis) sem avalia√ß√£o hormonal quando h√° suspeita de disfun√ß√£o androg√™nica.
- [ ] 9.

---

### Chunk 28/30
**Article:** MFI - Reposi√ß√£o Hormonal - AULA 06 (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.665

semana (segundas, quartas e sextas) antes de dormir.
   - A dose de 5 mg tem efeito antiestrog√™nico, afinando o endom√©trio, sem garantir anovula√ß√£o; mant√©m baixa probabilidade de gravidez.
   - Para quem deseja engravidar, n√£o √© boa op√ß√£o, pois o efeito antiestrog√™nico no endom√©trio pode dificultar a nida√ß√£o.
   - Doses menores (2‚Äì3 mg) podem contrabalan√ßar predomin√¢ncia estrog√™nica, caracterizada por gordura perif√©rica (bumbum, coxas) e abdominal.
* **Efeitos Androg√™nicos da Gestrinona**
   - Possui efeito androg√™nico (masculinizante) direto e reduz sensivelmente o SHBG (globulina ligadora de horm√¥nios sexuais).
   - A redu√ß√£o do SHBG aumenta a disponibilidade de DHT, podendo causar queda de cabelo, acne e oleosidade.
   - √â crucial avaliar testosterona e DHT antes de prescrever, especialmente em combina√ß√£o com testosterona, para evitar efeitos adversos. Critica-se a prescri√ß√£o excessiva e combinada de implantes sem avalia√ß√£o cuidadosa.

---

### Chunk 29/30
**Article:** Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome (2020)
**Journal:** International Journal of Molecular Sciences
**Section:** other | **Similarity:** 0.662

ededtoassesstheusefulnessofSHBGasabiomarkerforidentifyingyoungwomenwhomaylaterdevelopPCOS.AuthorContributions:BothauthorshavemadeequaleÔøΩortonwritingthisreview.Allauthorshavereadandagreedtothepublishedversionofthemanuscript.Funding:Thisreviewreceivednoexternalfunding.ConÔ¨ÇictsofInterest:TheauthorsdeclarenoconÔ¨Çictofinterest.AbbreviationsACCAcetyl-CoAcarboxylaseAESAndrogenexcesssocietyALTAlanineaminotransferaseASTAspartateaminotransferaseBMIBodymassindexCOCsCombinedoralcontraceptivesCVDCardiovasculardiseaseCYP17CytochromeP450family17DHEASDehydroepiandrosteronesulfateDNLDenovolipogenesisFSHFollicle-stimulatinghormoneGGT-GlutamyltransferaseGLUTGlucosetransportGnRHGonadotropin-releasinghormoneHDL-CHigh-densitylipoprotein-cholesterolHFDHighfatdietHepG2HepatomacellHNF-4ÔøΩHepatocytenuclearfactor4ÔøΩHOMA-IRHomeostaticmodelassessmentforinsulinresistanceIGTImpairedglucosetoleranceIRSInsulinreceptorsubstrateIL-1ÔøΩInterleukin-1ÔøΩIRInsulinresistanceLDLLow-densitylipoproteinLHLuteinizinghormo

---

### Chunk 30/30
**Article:** Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome (2020)
**Journal:** International Journal of Molecular Sciences
**Section:** other | **Similarity:** 0.658

MediatorsInÔ¨Çamm.2018,2018,3062319.[CrossRef][PubMed]65.Alinezhad,A.;Jafari,F.Therelationshipbetweencomponentsofmetabolicsyndromeandplasmalevelofsexhormone-bindingglobulin.Eur.J.Transl.Myol.2019,29,8196.[CrossRef]66.Siddiqui,K.;Al-Rubeaan,K.;Nawaz,S.S.;Aburisheh,K.H.;Alaabdin,A.M.Z.;Tolba,I.A.SerumSexHormoneBindingGlobulin(SHBG)RelationwithDiÔøΩerentComponentsofMetabolicSyndromeinMenwithType2Diabetes.Horm.Metab.Res.2018,50,138‚Äì144.[CrossRef]67.Faal,S.;Abedi,P.;Jahanfar,S.;Ndeke,J.M.;Mohaghegh,Z.;ShariÔ¨Åpour,F.;Zahedian,M.Sexhormonebindingglobulinforpredictionofgestationaldiabetesmellitusinpre-conceptionandpregnancy:Asystematicreview.DiabetesRes.Clin.Pract.2019,152,39‚Äì52.[CrossRef]68.JoÔøΩe,H.V.;Ridker,P.M.;Manson,J.E.;Cook,N.R.;Buring,J.E.;Rexrode,K.M.Sexhormone-bindingglobulinandserumtestosteroneareinverselyassociatedwithC-reactiveproteinlevelsinpostmenopausalwomenathighriskforcardiovasculardisease.Ann.Epidemiol.2006,16,105‚Äì112.[CrossRef][PubMed]69.Subramanya,V.;Zhao,D.;Ouyang

---

